Floatz logo

Therapeutic Asset Ratings

145 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Intismeran
Renal Cell Carcinoma
Merck Sharp & Dohme LLCP2CCC (48)
Pd-L1 T-Hank
Renal Cell Carcinoma
ImmunityBio, Inc.P2CCC (48)
Pucotenlimab
Renal Cell Carcinoma
Sun Yat-sen UniversityP2CCC (48)
ro7247669
Renal Cell Carcinoma
Hoffmann-La RocheP2CCC (48)
VIPIVOTIDE TETRAXETAN
Renal Cell Carcinoma
Dana-Farber Cancer InstituteP2CCC (48)
Zirconium Zr 89 Crefmirlimab Berdoxam
Renal Cell Carcinoma
ImaginAb, Inc.P2CCC (48)
Pyrotinib
Renal Cell Carcinoma
HiFiBiO TherapeuticsP1/2CC (46)
rc48-adc
Renal Cell Carcinoma
HiFiBiO TherapeuticsP1/2CC (46)
n-803
Renal Cell Carcinoma
ImmunityBio, Inc.P2CC (42)
Anti-Cd70-Car-T Cells
Renal Cell Carcinoma
Shanghai Changzheng HospitalP1CC (42)
cd70-targeting car-t cells
Renal Cell Carcinoma
Chongqing Precision Biotech Co., LtdP1CC (42)
a2b395
Renal Cell Carcinoma
A2 Biotherapeutics Inc.P1/2CC (41)
Alintegimod
Renal Cell Carcinoma
7 Hills Pharma, LLCP1/2CC (41)
azd6750
Renal Cell Carcinoma
AstraZenecaP1/2CC (41)
Bgb-A445
Renal Cell Carcinoma
BeiGeneP1/2CC (41)
FULVESTRANT
Renal Cell Carcinoma
Rain Oncology IncP1/2CC (41)
gen1160
Renal Cell Carcinoma
GenmabP1/2CC (41)
gm103
Renal Cell Carcinoma
GeneMedicine Co., Ltd.P1/2CC (41)
her2bbζ/cd19t+ t cells
Renal Cell Carcinoma
Shanghai Public Health Clinical CenterP1/2CC (41)
Inbrx-106
Renal Cell Carcinoma
Inhibrx Biosciences, IncP1/2CC (41)
Interleukin 18 (recombinant human mutein clone ST-067)
Renal Cell Carcinoma
Simcha IL-18, Inc.P1/2CC (41)
neo212
Renal Cell Carcinoma
Neonc Technologies, Inc.P1/2CC (41)
ngm707
Renal Cell Carcinoma
NGM Biopharmaceuticals, IncP1/2CC (41)
PEXMETINIB
Renal Cell Carcinoma
Dan ZandbergP1/2CC (41)
Regorafenib
Renal Cell Carcinoma
Neonc Technologies, Inc.P1/2CC (41)
Showing 51 to 75 of 145 assets
PreviousPage 3 of 6Next